Scripta Insights

Scripta Insights offers pharmacy benefit cost containment services, utilizing its Med Mapper™ AI software to help members find cost-effective medications and partners with Mark Cuban Cost Plus Drug Company to enhance access to affordable drugs.

Services

Scripta Insights offers a pharmacy benefit cost containment service designed to help members obtain the right medications at the best prices without needing to change their Pharmacy Benefit Managers (PBMs). They provide a free savings analysis to demonstrate potential cost savings for plans and their members. Scripta Insights offers tailored solutions for employers, consultants, Third Party Administrators (TPAs), and health plans. Their personalized savings reports suggest lower-priced prescription options, making the cost-savings process straightforward and accessible for members.

Technology and Tools

Scripta Insights uses the Med Mapper™ AI software to navigate prescription savings. This technology assists in identifying the most cost-effective medications for members, providing a technological edge in pharmacy benefit management. Additionally, they offer a mobile app that allows members to access their personalized savings reports and manage their prescriptions, streamlining the process of managing and reducing pharmacy costs.

Partnerships

Scripta Insights has partnered with Mark Cuban Cost Plus Drug Company to expand access to low-cost drug options. This partnership ensures that members have the ability to obtain necessary medications at reduced prices, further enhancing the cost-saving strategies employed by Scripta Insights.

Member Support

Scripta Insights provides a dedicated member support line that is available Monday through Friday from 9 a.m. to 5 p.m. EST. This support line serves as a valuable resource for members with questions or needs regarding their prescriptions and savings reports. The accessibility of this support underscores Scripta's commitment to member satisfaction and effective service delivery.

Companies similar to Scripta Insights